Hamers FP - Search Results

1

Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by alphaMSH and ORG 2766.

Hamers FP, Wijbenga J, Wolters FL, Klis SF, Sluyter S, Smoorenburg GF. Hamers FP, et al. Audiol Neurootol. 2003 Nov-Dec;8(6):305-15. doi: 10.1159/000073515. Audiol Neurootol. 2003. PMID: 14566101

2

Partial recovery of cisplatin-induced hearing loss in the albino guinea pig in relation to cisplatin dose.

Klis SF, O'Leary SJ, Wijbenga J, de Groot JC, Hamers FP, Smoorenburg GF. Klis SF, et al. Among authors: hamers fp. Hear Res. 2002 Feb;164(1-2):138-46. doi: 10.1016/s0378-5955(01)00425-7. Hear Res. 2002. PMID: 11950533

3

Co-treatment with melanotan-II, a potent melanocortin, does not protect against cisplatin ototoxicity.

Wolters FL, de Vocht TF, Klis SF, Hamers FP, Smoorenburg GF. Wolters FL, et al. Among authors: hamers fp. Hear Res. 2002 Oct;172(1-2):110-7. doi: 10.1016/s0378-5955(02)00551-8. Hear Res. 2002. PMID: 12361873

4

Systemic co-treatment with alpha-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs.

Wolters FL, Klis SF, de Groot JC, Hamers FP, Prieskorn DM, Miller JM, Smoorenburg GF. Wolters FL, et al. Among authors: hamers fp. Hear Res. 2003 May;179(1-2):53-61. doi: 10.1016/s0378-5955(03)00080-7. Hear Res. 2003. PMID: 12742238

5

Perilymphatic application of alpha-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin.

Wolters FL, Klis SF, Hamers FP, de Groot JC, Smoorenburg GF. Wolters FL, et al. Among authors: hamers fp. Hear Res. 2004 Mar;189(1-2):31-40. doi: 10.1016/S0378-5955(03)00396-4. Hear Res. 2004. PMID: 14987750

6

Application of a neuroprotective ACTH(4-9) analog to affect cisplatin ototoxicity: an electrocochleographic study in guinea pigs.

Hamers FP, Klis SF, Gispen WH, Smoorenburg GF. Hamers FP, et al. Eur Arch Otorhinolaryngol. 1994;251(1):23-9. doi: 10.1007/BF00175953. Eur Arch Otorhinolaryngol. 1994. PMID: 8179863

7

Reversible cisplatin ototoxicity in the albino guinea pig.

Klis SF, O'Leary SJ, Hamers FP, De Groot JC, Smoorenburg GF. Klis SF, et al. Among authors: hamers fp. Neuroreport. 2000 Feb 28;11(3):623-6. doi: 10.1097/00001756-200002280-00037. Neuroreport. 2000. PMID: 10718325

8

Perilymphatic application of cisplatin over several days in albino guinea pigs: dose-dependency of electrophysiological and morphological effects.

O'Leary SJ, Klis SF, de Groot JC, Hamers FP, Smoorenburg GF. O'Leary SJ, et al. Among authors: hamers fp. Hear Res. 2001 Apr;154(1-2):135-45. doi: 10.1016/s0378-5955(01)00232-5. Hear Res. 2001. PMID: 11423224

9

Co-administration of the neurotrophic ACTH(4-9) analogue, ORG 2766, may reduce the cochleotoxic effects of cisplatin.

de Groot JC, Hamers FP, Gispen WH, Smoorenburg GF. de Groot JC, et al. Among authors: hamers fp. Hear Res. 1997 Apr;106(1-2):9-19. doi: 10.1016/s0378-5955(96)00213-4. Hear Res. 1997. PMID: 9112103

10

Protection and spontaneous recovery from cisplatin-induced hearing loss.

Smoorenburg GF, De Groot JC, Hamers FP, Klis SF. Smoorenburg GF, et al. Among authors: hamers fp. Ann N Y Acad Sci. 1999 Nov 28;884:192-210. doi: 10.1111/j.1749-6632.1999.tb08642.x. Ann N Y Acad Sci. 1999. PMID: 10842594

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters